Frequency of sarcopenia and associated factors among hospitalized elderly patients

BMC Musculoskeletal Disorders

Aquiles Assunção Camelier¹  Fernanda Warken Rosa Camelier¹  Flávia Milholo Olivieri²  Isabela Barboza Gomes²  Anne Karine Menezes Santos Batista²  Bruno Prata Martinez¹ 

[1] State University of Bahia, Salvador, Bahia, Brazil;City Hospital, Salvador, Bahia, Brazil

关键词: Grip strength;    Mass muscle;    Hospital;    Elderly;    Sarcopenia;   

Others  :  1227783
DOI  :  10.1186/s12891-015-0570-x

 received in 2014-09-17, accepted in 2015-04-29,  发布年份 2015

【 摘 要 】

Background

Sarcopenia is an important public health problem that affects mainly elders, and has negative consequences, such as disability and even death. Due to the lack of studies evaluating sarcopenia in elderly persons hospitalized in Brazil, the aim of the present study was to describe the frequency of sarcopenia and associated factors among elders in a hospital in the city of Salvador - Brazil.

Methods

This cross-sectional study included 110 hospitalized elderly patients in a multi-specialty hospital in Salvador-BA, Brazil. Inclusion criteria: were elders aged ≥60 years between the first and fifth day of hospitalization; who were able to walk without external assistance; with medical permission to walk, and who did not take vasoactive and inotropic drugs. The diagnosis of sarcopenia was determined by combining the reduction in skeletal muscle mass with muscle weakness (women, <20 kg; men, <30 kg) and/or poor physical performance (gait speed ≤0.8 m/s). To obtain reduced skeletal muscle mass, the skeletal muscle mass index ≤6.37 kg/m² for women and ≤8.90 kg/m² for men was used. Cognitive function, Charlson index, admission profile (clinical and surgical), smoking, falls suffered in the last year and physical inactivity prior to admission were also evaluated. The frequency of sarcopenia was described in percentages with their respective confidence intervals and logistic regression was performed for multivariate analysis of factors associated with sarcopenia.

Results

Among the 110 patients included, the frequency of sarcopenia was 21.8%, with 10.0% being of the severe type. There was a predominance of clinical profile (59.1%), such as heart disease (20.0%), pneumonia (13.6%) and skin infections (9.1%), with a Charlson index of 5.4 ± 1.8. The factors associated with sarcopenia were age (OR = 1.14; 95% CI = 1.06 to 1.23), clinical profile on admission (OR = 5.15; 95% CI = 1.16–22.9) and smoking (OR = 7.8; 95% CI = 1.53–39.9).

Conclusions

The frequency of sarcopenia in elderly hospitalized patients was high (1 in 5 elderly) and anthropometric equation can be a viable and inexpensive alternative to screening and programming intervention in this population.

【 授权许可】

   
2015 Martinez et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Rosenberg IH. Summary comments. Am J Clin Nutr. 1989; 50:1231-33.
• [2]Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al.. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147:755-63.
• [3]Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al.. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412-23.
• [4]Cawthon PM, Marshall LM, Michael Y, Dam T, Ensrud KE, Barret-Connor E et al.. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007; 55:1216-23.
• [5]Di Monaco M, Vallero F, Di Monaco R, Tappero R. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr. 2011; 52:71-4.
• [6]Janssen I, Baumgartner RN, Ross R, Rosenberg IH. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004; 159:413-21.
• [7]Alexandre TS, Duarte YAO, Santos JLF, Wong R, Lebrão ML. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for disability in the elderly. J Nutr Health Aging. 2014; 18:547-53.
• [8]Gale CR, Martyn CN, Cooper C, Sayer AA. Grip strength, body composition, and mortality. Int J Epidemiol. 2007; 36:228-35.
• [9]Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB et al.. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006; 61A:72-7.
• [10]Alexandre TS, Duarte YAO, Santos JLF, Wong R, Lebrão ML. Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging. 2014; 18:751-6.
• [11]Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care. 2010; 13:271-6.
• [12]Melton LJ, Khosla S, Crowson CS, O’Connor MK, O’Fallon WM, Riggs BL. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000; 48:625-30.
• [13]Tichet J, Vol S, Goxe D, Salle A, Berrut G, Ritz P. Prevalence of sarcopenia in the French senior population. J Nutr Health Aging. 2008; 12:202-6.
• [14]Rech CR, Dellagrana RA, Marucci MFN, Petroski EL. Validity of anthropometric equations for the estimation of muscle mass in the elderly. Braz J Kineant. 2012; 14:23-31.
• [15]Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC et al.. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013; 42:378-84.
• [16]Alexandre TS, Duarte YAO, Santos JLF, Wong R, Lebrão ML. Prevalence and associated factors of sarcopenia among elderly in Brazil: Findings from the study SABE. J Nutr Health Aging. 2014; 18:284-90.
• [17]Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr. 2000; 72:796-803.
• [18]Cornette P, Swine C, Malhomme B, Gillet J, Meert P, D’Hoore W. Early evaluation of the risk of functional decline following hospitalization of older patients: development of a predictive tool. Eur J Public Health. 2006; 16:203-8.
• [19]Lohman TG, Roche AF, Mortel R. Antrhropometric standardization reference manual. Human kinetics, Champaign, IL; 1998.
• [20]Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M et al.. Sarcopenia: Alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003; 51:1602-9.
• [21]Delmonico MJ, Harris TB, Lee J, Visser M, Nevitt M, Kritchevsky SB et al.. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007; 55:769-74.
• [22]Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994; 21:55-67.
• [23]Reis MM, Arantes PMM. Medida da força de preensão manual – validade e confiabilidade do dinamômetro Saehan. Fisioter Pesquisa. 2011; 18:176-181.
• [24]Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di lorio A et al.. Age-associated changes in skeletal muscles and their effect on mobility : an operational diagnosis of sarcopenia. J Appl Phys. 2003; 95:1851-60.
• [25]Kan GAV, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M et al.. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an international academy on nutrition and aging (IANA) task force. J Nutr Health Aging. 2009; 13:881-9.
• [26]Lourenço RA, Veras RP. Mini-mental State Examination: psychometric characteristics in elderly outpatients. Rev Saude Publica. 2006; 40:712-9.
• [27]Batista FS, Gomes GAD, Neri AL, Guariento ME, Cintra FA, Sousa MLR et al.. Relationship between lower-limb muscle strength and frailty among elderly people. Sao Paulo Med J. 2012; 130(2):102-8.
• [28]Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-83.
• [29]Zaitune MPA, Barros MBA, Lima MG, César CLG, Carandina L, Goldbaum M et al.. Factors associated with smoking in the elderly: a health survey in São Paulo (ISA-SP). Cad Saude Publica. 2012; 28(3):583-95.
• [30]Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. World Health Organization, Geneva; 1991.
• [31]Gariballa SE, Alessa A. Sarcopenia: Prevalence and prognostic significance in hospitalized patients. Clin Nutr. 2013; 32:772-6.
• [32]Yamada M, Nishiguchi S, Fukutani N, Tanigawa T, Yukutake T, Kayama H et al.. Prevalence of sarcopenia in community-dwelling Japanese older adults. J Am Med Dir Assoc. 2013; 14:911-5.
• [33]Legrand D, Vaes B, Mathei C, Swine C, Degryse J. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing. 2013; 42:727-34.
• [34]Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G et al.. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010; 29:154-9.
• [35]Gariballa SE, Forster S. Effects of acute phase response on nutritional status and clinical outcome of hospitalised patients. Nutrition. 2006; 22:750-7.
• [36]McNeil CJ, Doherty TJ, Stahuk DW, Rice CL. Motor unit number estimates in the tibialis anterior muscle of young, old, and very old men. Muscle Nerve. 2005; 31:461-7.
• [37]Rom O, Kaisari S, Aizenbud D, Reznick AZ. Identification of possible cigarette smoke constituents responsible for muscle catabolism. J Muscle Res Cell Motil. 2012; 33:199-208.
• [38]Abbiss CR, Laursen PB. Models to explain fatigue during prolonged endurance cycling. Sports Med. 2005; 35:865-98.
• [39]Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF. Central fatigue. The serotonin hypothesis and beyond. Sports Med. 2006; 36:881-909.
• [40]Kan GA, Cesari M, Gillette-Guyonnet S, Dupuy C, Nourhashémi F, Schott A et al.. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013; 42:196-202.